WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June.
WILMINGTON, Del., June 03, 2024 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in two upcoming healthcare conferences in June.
PRELUDE THERAPEUTICS INC
NASDAQ:PRLD (2/11/2025, 3:04:02 PM)
0.92
-0.17 (-15.6%)
Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.